Michael Castagna
Vorstandsvorsitzender bei MANNKIND CORPORATION
Vermögen: 9 Mio $ am 30.04.2024
Aktive Positionen von Michael Castagna
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MANNKIND CORPORATION | Direktor/Vorstandsmitglied | 25.05.2017 | - |
| Vorstandsvorsitzender | 25.05.2017 | - | |
| Corporate Officer/Principal | 14.03.2016 | 25.05.2017 | |
| Pet Partners | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Michael Castagna
Ehemalige bekannte Positionen von Michael Castagna
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01.11.2012 | 14.03.2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2010 | 01.11.2012 |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01.04.2009 | 01.11.2010 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Direktor/Vorstandsmitglied | 01.10.2005 | - |
| NOVARTIS AG | Corporate Officer/Principal | - | - |
Ausbildung von Michael Castagna
| Massachusetts College of Pharmacy & Health Science | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Philadelphia College of Pharmacy | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 10 |
| Schweiz | 2 |
Operativ
| Corporate Officer/Principal | 5 |
| Director/Board Member | 3 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
| Pet Partners |
- Börse
- Insiders
- Michael Castagna
- Erfahrung
